DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



The Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Zinc Supplement

Information source: Siriraj Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Female Pattern Alopecia

Intervention: 15 mg Chelate zinc supplement (Drug); Placebo drug supplement (Drug)

Phase: Phase 1/Phase 2

Status: Recruiting

Sponsored by: Siriraj Hospital

Overall contact:
Rattapon Thuangtong, MD, Phone: +662 419-7000, Ext: 4333, Email: rattapongthuangtong@yahoo.com

Summary

Zinc supplement is a popular trace element gave to Female pattern hair loss (FPHL) patient. But the type of patient, efficacy, and side effect in detail of zinc supplement are not well characterized. The purpose of this study is to determine efficacy and side effect of chelated zinc in FPHL who using 5%minoxidil solution.

Clinical Details

Official title: A Pilot Study of the Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Oral Chelated Zinc Supplement

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Primary outcome:

Compare clinical improvement before and after treatment

Compare hair density before and after treatmen

Compare average hair shaft diameter before and after treatment

Secondary outcome: Number of pateint with Side effect

Detailed description: 5%minoxidil solution is standard treatment for Female pattern hair loss (FPHL) patient. We gave 15mg chelate Zinc / Placebo drug to patient as an additional trace element. Then measure growth of hair by Global photograph, Microscope hair count, micrometer and record case and side effect during 10 months of treatment.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Female Pattern Hair Loss ( Ludwig classification grade 1 and 2 )

Exclusion Criteria:

- Underlying disease ; Anemia, Diabetes, chronic alcoholism, previous gastrointestinal

surgery, short bowel syndrome, Crohn's disease, digestive disorder, hypo/hyperthyroidism, sickle cell disease, autoimmune disease, iron deficiency

- Psychologic disorder trichotillomania

- Diet control

- Pregnancy or lactation

- On supplement diet within 3 month prior to trial

Locations and Contacts

Rattapon Thuangtong, MD, Phone: +662 419-7000, Ext: 4333, Email: rattapongthuangtong@yahoo.com

Siriraj Hospital, Bangkok 10700, Thailand; Recruiting
Rattapon Thuangtong, MD, Phone: +662 419-7000, Ext: 4333, Email: rattapongthuangtong@yahoo.com
Additional Information

Starting date: January 2012
Last updated: August 7, 2012

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017